Mutations of the ret protooncogene in German multiple endocrine neoplasia families: Relation between genotype and phenotype

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 5, 1996, Pages 1780-1783

  Frank Raue, K ^a   Hoppner W ^b   Frilling, A ^c   Kotzerke, J ^d   Dralle, H ^d   Haase, R ^e   Mann, K ^e   Seif, F ^f   Kirchner, R ^g   Rendl, J ^h   Deckart, H F ⁱ   Ritter, M M ^j   Hampel, R ^k   Klempa, J ^l   Scholz, G H ^m   Raue, F ^a   Bogner, U ⁿ   Brabant, G ⁿ   Grussendorf, M ⁿ   Hartenstein, C H ⁿ   Heidemann, P ⁿ   Hensen, J ⁿ   Dorr A G ⁿ   Hohne T ⁿ   Hornig Franz I ⁿ   Hufner M ⁿ   Kress J ⁿ   Langer, H J ⁿ   Lottermoser, K ⁿ   Schweikert, H U ⁿ   Kusterer, K ⁿ   Menken, U ⁿ   Mercier, J ⁿ   Oelkers, W ⁿ   Sauer, J ⁿ   Simon, D ⁿ   Starrach, G ⁿ   Ziegler, R ⁿ   more..

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Inst F Hormon F   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Abteilung Nuklearmedizin   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g UNIVERSITY HOSPITAL MARBURG   (Germany)

^h UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

ⁱ HELIOS KLINIKUM BERLIN BUCH   (Germany)

^j LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^k ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^l Chirurgische Klinik   (Germany)

^m UNIVERSITY HOSPITAL LEIPZIG   (Germany)

ⁿ NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT;

ARTICLE; FAMILY STUDY; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE; GERMANY; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MULTIPLE ENDOCRINE NEOPLASIA; NEUROFIBROMATOSIS; PHENOTYPE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTO ONCOGENE; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARCINOMA, MEDULLARY; CODON; DROSOPHILA PROTEINS; EXONS; GENOTYPE; GERMANY; MOLECULAR SEQUENCE DATA; MULTIPLE ENDOCRINE NEOPLASIA; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MUTATION; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 9344234978     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.5.1780     Document Type: Article

References (19)

1. Raue F, Frank-Raue K, Grauer A. 1994 Multiple endocrine neoplasia type 2, clinical features and screening. Endocrin Metab Clin North Am. 23:137-156.
2. Donis-Keller H, Dou S, Chi D, et al. 1993 Mutations in the RET protooncogene are associated with MEN 2A and FMTC. Hum Molec Genetics. 2:851-856.
3. Mulligan LM, Eng C, Healey CS, et al. 1994 Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet. 6:70-74.
4. Mulligan LM, Kwok JBJ, Healey CS, et al. 1993 Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2a (MEN 2A). Nature. 363:458-469.
5. Schuffenecker I, Billaud M, Calender A, et al. 1994 RET proto-oncogene mutations in French MEN 2A and FMTC families. Hum Mol Genet. 3:1939-1943.
6. Tsai M-S, Ledger GA, Khosla S, Gharib H, Thibodeau SN. 1994 Identification of multiple endocrine neoplasia, type 2 gene carriers using linkage analysis of the RET proto-oncogene. J Clin Endocrinol Metab. 78:1261-1264.
7. Carlson KM, Dou S, Chi D, et al. 1994 Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA. 91:1579-1583.
8. Eng C, Smith DP, Mulligan LM, et al. 1994 Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet. 3:237-241.
9. Hofstra RMW, Landsvater RM, Ceccherini I, et al. 1994 A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type-2B and sporadic medullary thyroid carcinoma. Nature. 367:375-376.
10. Rossel M, Schuffenecker I, Schlumberger M, et al. 1995 Detection of a germ-line mutation at codon 918 of the RET proto-oncogene in French MEN 2B families. Hum Genet. 95:403-406.
11. Santora M, Carlomagno F, Romano A, et al. 1995 Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science. 267:381-383.
12. Lips CJM, Landsvater RM, Höppener JWM, et al. 1994 Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med. 331:828-835.
13. Wells SA, Chi DD, Toshima K, et al. 1994 Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2a. Ann Surg. 220:237-250.
14. Feldmann GL, Kambouris M, Talpos GB, Mulligan LM, Ponder BAJ, Jackson CE. 1994 Clinical value of direct DNA analysis of the RET proto-oncogene in families with multiple endocrine neoplasia type 2A. Surgery. 116:1042-1047.
15. Ledger GA, Khosla S, Lindor NM, Thibodeau SN, Gharib H. 1995 Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II. Ann Intern Med. 122:118-124.
16. Quadro L, Panariello L, Salvatore D, et al. 1994 Frequent RET protooncogene mutations in multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab. 79:590-594.
17. Xue F, Yu H, Maurer LH, et al. 1994 Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests. Hum Mol Genet. 3:635-638.
18. Eng C, Smith DP, Mulligan LM, et al. 1995 A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene. 10:509-513.
19. Narod SA, Sobol H, Nakamura Y, et al. 1989 Linkage analysis of hereditary thyroid carcinoma with and without pheochromocytoma. Hum Genet. 83: 353-358.